The prevalence of rabies and typhoid fever in many developing countries poses a serious health hazard to travellers. The development of a combined immunization schedule would be advantageous. A study was performed on 104 adult volunteers using purified Vero cell rabies vaccine and Typhim Vi, a purified capsular polysaccharide, either separately or in combination. No significant difference was observed in immunogenicity or tolerance between the two groups. A 3-year follow-up study is planned.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0264-410x(92)90366-r | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!